Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

19

Revenue 2014

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

EMA approves GSK’s triple COPD therapy

EMA approves GSK’s triple COPD therapy COPD sector from the likes of AstraZeneca, Novartis and Boehringer Ingelheim, which have all launched their own fixed-dose combination products, analysts reckon Trelegy represents its biggest commercial opportunity.

Boehringer claims EU okay for Humira biosimilar

Boehringer claims EU okay for Humira biosimilar Boehringer Ingelheim has picked up its first EU approval for a biosimilar drug, getting a green light from the EMA for its version of AbbVie’s blockbuster immunotherapy Humira. ... The approval does not mean that Boehringer will launch its biosimilar

Boehringer builds evidence base for its Humira biosimilar

Boehringer builds evidence base for its Humira biosimilar Boehringer Ingelheim has released positive phase III data for Cyltezo (adalimumab-adbm), its biosimilar version of AbbVie’s blockbuster arthritis treatment Humira. ... Humira. Karsten Kissel, head of global medical affairs biosimilars, Boehringer

Dupixent dulls pain of diabetes slump at Sanofi

Dupixent dulls pain of diabetes slump at Sanofi The group was also lifted by its asset swap with Boehringer Ingelheim, which expanded its consumer health operations. ... Meanwhile Lantus (insulin glargine) fell almost 16% to 1.12bn thanks to continued take-up of biosimilar versions from the likes of

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....
the_other_side_of_multiple_sclerosis_thumb.jpg
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
“My sister went without treatment despite relapses - enough was enough, I had to intervene”...

Infographics